Daisy Clean Sanitizer
Hypochlorous Acid
Jd Corporation
Human Otc Drug
NDC 75696-0008Daisy Clean Sanitizer also known as Hypochlorous Acid is a human otc drug labeled by 'Jd Corporation'. National Drug Code (NDC) number for Daisy Clean Sanitizer is 75696-0008. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Daisy Clean Sanitizer drug includes Hypochlorous Acid - .005 g/100mL . The currest status of Daisy Clean Sanitizer drug is Active.
Drug Information:
| Drug NDC: | 75696-0008 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Daisy Clean Sanitizer |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Hypochlorous Acid |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Jd Corporation |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Liquid |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | HYPOCHLOROUS ACID - .005 g/100mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 06 Oct, 2021 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 22 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | JD corporation
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | 712K4CDC10
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 75696-0008-1 | 100 mL in 1 BOTTLE (75696-0008-1) | 06 Oct, 2021 | N/A | No |
| 75696-0008-2 | 500 mL in 1 BOTTLE (75696-0008-2) | 06 Oct, 2021 | N/A | No |
| 75696-0008-3 | 4000 mL in 1 CONTAINER (75696-0008-3) | 06 Oct, 2021 | N/A | No |
| 75696-0008-4 | 20000 mL in 1 CONTAINER (75696-0008-4) | 06 Oct, 2021 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose disinfecting agent
Product Elements:
Daisy clean sanitizer hypochlorous acid water hypochlorous acid hypochlorous acid
Indications and Usage:
Uses sterilization, disinfection
Warnings:
Warning for external use only when using this product ⢠if followmg abnormal symptoms persist, discontinue use irritation around the eyes. ears, mucous membranes. including the mouth.under the skin irritation and rashes ⢠stop immediately and consult a doctor if you experience 1) hypersensitivity symptoms such as erythema, itching and dermatitis. 2) skin irritation 3) following instructions when using medication (1) for external use only (do not use internally) (2) avoid gelling into the eyes (if contact occurs, wash well with clean water) ⢠be careful not to inhale or use excessively for a long time (ingesting ethanol repeatedly causes irritation to mucous membranes and headaches or other symptoms may appear. when used repeatedly in the same area, skin irritation may occur. ⢠do not use the product for a tong time in the same area as swelling, inflammation or sickness may occur due to absorption through the skin. it is not recommended using this one area that have
Read more...been medically treated with a cast or bandage. ⢠do not use in combination with soap or antibacterial cleansing agents.
Dosage and Administration:
Directions take appropriate amount where needed
Package Label Principal Display Panel:
Product label image description image description image description image description image description